Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Obalon Therapeutics Inc (OBLN)

Obalon Therapeutics Inc (OBLN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,294
  • Shares Outstanding, K 31,001
  • Annual Sales, $ 9,100 K
  • Annual Income, $ -37,380 K
  • 60-Month Beta -5.33
  • Price/Sales 2.01
  • Price/Cash Flow N/A
  • Price/Book 2.17
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.53
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/01/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.27
  • Number of Estimates 3
  • High Estimate -0.17
  • Low Estimate -0.40
  • Prior Year 0.57
  • Growth Rate Est. (year over year) -147.37%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.55 +9.60%
on 07/05/19
0.87 -30.26%
on 06/25/19
unch (-0.02%)
since 06/19/19
3-Month
0.37 +63.51%
on 05/20/19
1.92 -68.49%
on 05/30/19
+0.14 (+29.14%)
since 04/18/19
52-Week
0.37 +63.51%
on 05/20/19
3.70 -83.65%
on 09/12/18
-1.25 (-67.47%)
since 07/19/18

Most Recent Stories

More News
Obalon Obtains Two New U.S. Patents Covering Its Proprietary Intragastric Balloon System

Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of...

OBLN : 0.61 (+2.53%)
Obalon Strengthens Balance Sheet By Raising Additional Capital And Reducing Debt

Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of...

OBLN : 0.61 (+2.53%)
LPBC : 9.5000 (-4.52%)
Bariatric Medical Institute of Texas Presents Favorable Study Results for Obalon Balloon Administration Using Navigation Device and Touch Dispenser

Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of...

OBLN : 0.61 (+2.53%)
Obalon Appoints Bob MacDonald as Chief Retail Officer

Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of...

OBLN : 0.61 (+2.53%)
Hottest Wall Street Stories: What's Up, What's Down

Tariff tantrums hit the broader stock markets last month, leading to the worst May after 2010. Below we discuss these in detail and the impact on the stock world from these events.

NVDA : 168.44 (-1.02%)
RGSE : 0.2299 (-0.04%)
OTLK : 2.45 (-6.84%)
AAPL : 202.59 (-1.49%)
HK : 0.17 (-3.67%)
GM : 39.48 (+0.92%)
F : 10.20 (-0.58%)
MU : 45.52 (+1.90%)
FCAU : 13.37 (-2.12%)
OBLN : 0.61 (+2.53%)
QCOM : 75.00 (+0.85%)
FTDR : 46.05 (+0.15%)
OESX : 2.92 (+2.10%)
PES : 0.22 (unch)
ACA : 36.44 (-0.76%)
OBALON THERPTCS (OBLN) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, OBALON THERPTCS (OBLN) closed at $0.68, marking a -0.37% move from the previous day.

OBLN : 0.61 (+2.53%)
Thinking about buying stock in Avon Products, Genocea Biosciences, L Brands, Netshoes, or Obalon Therapeutics?

InvestorsObserver issues critical PriceWatch Alerts for AVP, GNCA, LB, NETS, and OBLN.

OBLN : 0.61 (+2.53%)
NETS : 3.70 (-2.63%)
GNCA : 3.63 (-0.82%)
LB : 25.84 (-2.01%)
AVP : 3.97 (+0.51%)
OBALON THERPTCS (OBLN) Dips More Than Broader Markets: What You Should Know

OBALON THERPTCS (OBLN) closed the most recent trading day at $0.42, moving -1.96% from the previous trading session.

OBLN : 0.61 (+2.53%)
Obalon Announces Receipt of Delisting Notification Letters from Nasdaq

Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of...

OBLN : 0.61 (+2.53%)
Investor Expectations to Drive Momentum within United Rentals, The Medicines, Unilever, and OBALON THERPTCS -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of United Rentals, Inc. (NYSE:URI),...

OBLN : 0.61 (+2.53%)
MDCO : 36.06 (-2.54%)
UL : 62.36 (-1.50%)
URI : 118.98 (-1.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Trade OBLN with:

Business Summary

Obalon Therapeutics, Inc. is a medical device company. It focused on developing and commercializing medical devices to treat obese and overweight. The company's product consists of Obalon balloon system, the first swallowable, gas-filled intragastric balloon designed to provide progressive and sustained...

See More

Key Turning Points

2nd Resistance Point 0.65
1st Resistance Point 0.63
Last Price 0.61
1st Support Level 0.59
2nd Support Level 0.57

See More

52-Week High 3.70
Fibonacci 61.8% 2.43
Fibonacci 50% 2.04
Fibonacci 38.2% 1.64
Last Price 0.61
52-Week Low 0.37

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar